Publications

• Jerlich A, Schaur RJ, Pitt AR, Spickett CM.
  The formation of phosphatidylcholine oxidation products by stimulated phagocytes.
  Free Radical Research 37:645-653, 2003.
• Jerlich A, Hammel M, Horakova L, Schaur RJ.
  An improved method for the sensitive monitoring of low density lipoprotein modification by myeloperoxidase.
  Redox Report 6:257-264, 2001. [Abstract]

• Sovic A, Borovic S, Loncaric I, Kreuzer T, Zarkovic K, Vukovic T, Wäg G, Hrascan R, Wintersteiger R, Klinger R, Zurak N, Schaur RJ, Zarkovic N.
  The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins.
  Anticancer Res 21:1997-2004, 2001.
  
  

• Spickett C, Rennie N, Winter H, Zambonin L, Landi L, Jerlich A, Schaur RJ, Pitt AR.
  Detection of phospholipid oxidation in oxidatively stressed cells by liquid chromatography-mass spectrometry.
  Biochem J 355:449-457, 2001. [Abstract]



• Wonisch W, Zellnig G, Kohlwein SD, Schaur RJ, Bilinski T, Tatzber F, Esterbauer H.
  Ultrastructural analysis of HNE treated Saccharomyces cerevisiae cells reveals fragmentation of the vacuole and an accumulation of lipids in the cytosol.
  Cell Biochem Funct 19:59-64, 2001.



• Poli G, Schaur RJ.
  4-hydroxynonenal in the pathomechanisms of oxidative stress.
  IUBMB Life 50:315-321, 2000. [Abstract]



• Spickett C, Jerlich A, Panasenko OM, Arnhold J, Pitt AR, Stelmaszynska T, Schaur RJ.
  The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids.
  Acta Biochim Pol 47:889-899, 2000.



• Bilban M, Barth S, Cervar M, Mauschitz R, Schaur RJ, Zivkovic F, Desoye G.
  Differential regulation of endothelin secretion and endothelin receptor mRNA levels in JAR, JEG-3, and BeWo choriocarcinoma cell lines in human trophoblasts, their nonmalignant counterpart.
  Arch Biochem Biophys 382:245-252, 2000.



• Khoschsorur GA, Winklhofer-Roob BM, Rabl H, Auer Th, Peng Z, Schaur RJ.
  Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials.
  Chromatographia 52:181-184, 2000.



• Jerlich A, Fritz G, Kharrazi H, Hammel M, Tschabuschnig S, Glatter O, Schaur RJ.
  Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation.
  Biochim Biophys Acta 1481:109-118, 2000.



• Jerlich A, Hammel M, Nigon F, Chapman MJ, Schaur RJ.
  Kinetics of tryptophan oxidation in plasma lipoproteins by myeloperoxidase-generated HOCl.
  Eur J Biochem 267:4137-4143, 2000.



• Jerlich A*, Tschabuschnig S*, Fabjan JS, Schaur RJ.
  Kinetics of chlorination of monochlorodimedone by myeloperoxidase.
  Int J Clin Lab Res 30:33-37, 2000.



• Jerlich A, Pitt AR, Schaur RJ, Spickett CM.
  Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS.
  Free Radic Biol Med 28:673-682, 2000.



• Jerlich A*, Horakova L*, Fabjan JS, Giessauf A, Jürgens G, Schaur RJ.
  Correlation of low density lipoprotein modification by myeloperoxidase with hypochlorous acid formation.
  Int J Clin Lab Res 29: 155-161, 1999.



• Zarkovic N, Zarkovic K, Schaur RJ, Stolc S, Schlag G, Redl H, Waeg G, Borovic S, Loncaric I, Juric G, Hlavka V.
  4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor.
  Life Sci 65:1901-1094, 1999.



• Schaur RJ, Jerlich A, Stelmaszynska T.
  Hypochlorous acid as reactive oxygen species.
  Curr Top Biophys 22:176-185, 1998.



• Wonisch W, Schaur RJ.
  Treatment of the budding yeast saccharomyces cerevisiae with the lipid peroxidation product 4-HNE provokes a temporary cell cycle arrest in G1-phase.
  Free Rad Biol Med 25:682-687, 1998.



• Jerlich A, Fabjan JS, Tschabuschnig S, Smirnova AV, Horakova L, Hayn M, Auer H, Guttenberger H, Leis H-J, Tatzber F, Waeg G,  Schaur RJ.
  Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
  Free Rad Biol Med 24:1139-1148, 1998.



• Kreuzer T, Grube R, Wutte A, Zarkovic N, Schaur RJ.
  4-Hydroxynonenal modifies the effects of serum growth factors on the expression of the c-fos proto-oncogene and the proliferation of HeLa carcinoma cells.
  Free Rad Biol Med 25:42-49, 1998.



• Wonisch W, Hayn M, Schaur RJ, Tatzber F, Kranner I, Grill D, Winkler R, Bilinski T, Kohlwein SD, Esterbauer H.
  Increased stress parameter synthesis in the yeast saccharomyces cerevisiae after treatment with 4-hydroxy-2-nonenal.
  FEBS Letters 405:11-15, 1997.



• Hammer A, Ferro M, Tillian HM, Tatzber F, Zollner H, Schauenstein E, Schaur RJ.
  Effect of oxidative stress by iron on 4-hydroxynonenal formation and proliferative activity in hepatomas of different degrees of differentiation.
  Free Radic Biol Med 23:26-33, 1997.



• Kukovetz EM, Bratschitsch G, Hofer HP, Egger G, Schaur RJ.
  Influence of age on the release of reactive oxygen species by phagocytes as measured by a whole blood chemiluminescence assay.
  Free Radic Biol Med 22:433-438, 1997.



• Schaur RJ, Curzio M.
  On the role of hydroxyalkenals in inflammation.
  Curr Top Biophys 18:238-244, 1995.



• Strohmaier H, Hinghofer-Szalkay H, Schaur RJ.
  Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma.
  J Lipid Mediat Cell Signal 11:51-61, 1995.



• Zarkovic N, Schaur RJ, Puhl H, Jurin M, Esterbauer H.
  Mutual dependence of growth modifying effects of 4-hydroxynonenal and fetal calf serum in vitro.
  Free Radic Biol Med 16:877-884, 1994.



• Schaur RJ, Dussing G, Kink E, Schauenstein E, Posch K, Kukovetz E, Egger G.
  The lipid peroxidation product 4-hydroxynonenal is formed by - and is able to attract - rat neutrophils in vivo.
  Free Radic Res 20:365-373, 1994.



• Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H.
  Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxy-nonenal.
  Cell Biochem Funct 11:279-286, 1993.



• Stelmaszynska T, Kukovetz E, Egger G, Schaur RJ.
  Possible involvement of myeloperoxidase in lipid peroxidation.
  Int J Biochem 24:121-128, 1992.